Faris A, Ljungh A, Wadström T
Zentralbl Bakteriol Mikrobiol Hyg A. 1985 Jul;259(4):477-84. doi: 10.1016/s0176-6724(85)80079-1.
Specific antisera for CFA/I (O78), CFA/II (O6) or enteropathogenic (EPEC) somatic O-antigens (serogroups O26, O86a and O111) were adsorbed to Staphylococcus aureus (strain Cowan I) to produce coagglutination reagents. Conventional agglutination tests with bacterial cells showed that antiserum against strain C922a-1 reacted with strain C91f, whereas anti-C91f did not agglutinate cells of strain C922a-1. Antisera raised against strains 4334f and C91f agglutinated their bacterial cells. Anti-303d did not react with strains C922a-1, 91f, nor with 4334f. Similar results were obtained with tests performed with COA-reagents of the above strains. Homologous antisera diluted 1:1000 gave positive COA reaction, after being adsorbed to Cowan I. Such diluted antisera gave negative agglutination reaction in the conventional agglutination tests. The COA test is at least 100 times more sensitive than the conventional agglutination tests. Hence, preparation of COA reagents implies practically economical use of antisera. Furthermore, the COA technique is much more sensitive and rapid (less than 5 min) than immunodiffusion test which takes greater than or equal to 24 h to read and in which large molecular weight antigens fail to diffuse in to agarose. 30 CFA/I strains (100%) gave COA positive reaction and only 25 CFA/II strains (71,4%) were positive with CFA/II COA reagents. The coagglutination technique was also applicable to identification of enteropathogenic E. coli by using somatic O-antigens (O26, O86a and O111) antisera.(ABSTRACT TRUNCATED AT 250 WORDS)
针对CFA/I(O78)、CFA/II(O6)或肠致病性(EPEC)菌体O抗原(血清群O26、O86a和O111)的特异性抗血清吸附到金黄色葡萄球菌(考恩I菌株)上,以制备协同凝集试剂。用细菌细胞进行的常规凝集试验表明,针对C922a - 1菌株的抗血清与C91f菌株反应,而抗C91f血清不能凝集C922a - 1菌株的细胞。针对4334f和C91f菌株产生的抗血清能凝集它们的细菌细胞。抗303d血清与C922a - 1、91f菌株以及4334f菌株均无反应。用上述菌株的协同凝集试剂进行测试也得到了类似结果。同源抗血清经1:1000稀释后吸附到考恩I菌株上,可产生阳性协同凝集反应。这种稀释后的抗血清在常规凝集试验中呈阴性凝集反应。协同凝集试验的灵敏度至少比常规凝集试验高100倍。因此,制备协同凝集试剂意味着抗血清的实际经济使用。此外,协同凝集技术比免疫扩散试验更灵敏、更快速(不到5分钟),免疫扩散试验读取结果需要大于或等于24小时,且大分子抗原无法扩散到琼脂糖中。30株CFA/I菌株(100%)呈协同凝集阳性反应,只有25株CFA/II菌株(71.4%)在用CFA/II协同凝集试剂检测时呈阳性。协同凝集技术也可通过使用菌体O抗原(O26、O86a和O111)抗血清来鉴定肠致病性大肠杆菌。(摘要截选至250字)